Search

everythinglearnresearchcommunity

for

Search:↓

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

GD-23 reduces anxiety by relying on neurosteroid production.

Certain alkaloids could help create new coronavirus drugs.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Copaiba resin oil shows promise for cancer therapy and is safe for topical use.

CBD may help manage severe lung issues in COVID-19 patients.

MC-1R is present in skin cells and may help reduce inflammation.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Acute stress increases Y1 receptor gene expression in certain brain areas, but repeated stress does not.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

The research shows how certain drugs can form stable structures with polymers, which is important for making new pharmaceuticals.

Compound 15a was effective in inhibiting 5α-reductase.

The document concludes that the androgen receptor's structure and function are complex, affecting how it regulates genes and is involved in diseases like prostate cancer.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.